ATLN vs FLYX
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The Advanced Deterministic Scorecard reveals a critically weak financial health profile with a Piotroski F-Score of just 2/9, indicating severe operational and financial distress. Despite a recent short-term price surge of +199.2% over one month, the company remains deeply unprofitable with negative margins across all key metrics, including a -22.66% profit margin and -16.64% ROA. Valuation metrics are distorted by negative book value (Price/Book: -9.75), and the lack of Altman Z-Score due to structural issues suggests potential bankruptcy risk. While the sector peers show mixed performance, ATLN’s fundamentals and deteriorating earnings trajectory—missing estimates by -11.1%—undermine any sustainable recovery case.
FLYX exhibits severe financial distress, anchored by a weak Piotroski F-Score of 2/9 and a critical liquidity crisis evidenced by a Current Ratio of 0.28. The company possesses negative equity (Price/Book of -0.21), indicating that liabilities exceed assets, which renders traditional valuation models like the Graham Number inapplicable. Despite modest revenue growth of 14.1%, the company has failed to beat earnings estimates in the last four quarters with a catastrophic average surprise of -976.19%. The technical trend is aggressively bearish, with a 47.9% decline over the last six months.
Compare Another Pair
Related Comparisons
ATLN vs FLYX: Head-to-Head Comparison
This page compares Atlantic International Corp. (ATLN) and flyExclusive, Inc. (FLYX) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.